Fenwick, Elisabeth

Model Parameter Estimation and Uncertainty Analysis: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group–6

Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Medical Decision Making

Health Systems, Economic Evaluations, Quality of LifeDelphi Technique in Research

Cited by 887

Model Parameter Estimation and Uncertainty: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-6

Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Value in Health

Health Systems, Economic Evaluations, Quality of LifeDelphi Technique in Research

Cited by 711

A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trial

Hunt, K., Wyke, S., Gray, C. M., Anderson, A. S., Brady, A., Bunn, C., Donnan, P. T., Fenwick, E., Grieve, E., Leishman, J., et al. (2014) · The Lancet

Obesity, Physical Activity, DietPhysical Activity and Health

Cited by 394

Meta‐analysis of the association between body mass index and health‐related quality of life among adults, assessed by the SF‐36

Ul‐Haq, Z., Mackay, D. F., Fenwick, E., & Pell, J. P. (2013) · Obesity

Obesity, Physical Activity, DietHealth Systems, Economic Evaluations, Quality of Life

Cited by 311

The management of Otitis Media with Effusion in children with cleft palate (mOMEnt): a feasibility study and economic evaluation

Bruce, I., Harman, N., Williamson, P., Tierney, S., Callery, P., Mohiuddin, S., Payne, K., Fenwick, E., Kirkham, J., & O’Brien, K. (2015) · Health Technology Assessment

Ear Surgery and Otitis MediaCleft Lip and Palate Research

Cited by 65

Uncertainty and Cures: Discontinuation, Irreversibility, and Outcomes-Based Payments: What Is Different About a One-Off Treatment?

Towse, A., & Fenwick, E. (2019) · Value in Health

Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and Policy

Cited by 32